University of California San Francisco
Immunotherapy Delays Type 1 Diabetes Onset in People at High Risk
A two-week course of an experimental immunotherapy called teplizumab dramatically reduced type 1 diabetes (T1D) diagnosis rates in people at high risk for the disease, according to newly published phase II clinical trial results. This is the first time a drug has been able to delay or prevent the disease, which affects 2 million people in the United States.
Slideshow: UCSF Commencement 2019
See the caps and gowns, smiles, tears and laughter from this year's commencements.
UCSF Mourns the Loss of Herb Sandler
Sandler was a longtime advocate of UCSF’s basic science and neurosciences research efforts.
Celebrating 20 Years of the UCSF Program for Breakthrough Biomedical Research
The program, supported by philanthropists Herb and Marion Sandler, funds ideas that challenge generally-accepted theories and have potentially transformative effects.
A Little Formula in First Days of Life May Not Impact Breastfeeding at 6 Months
A study has lodged a new kink in the breastfeeding dilemma that adds to the angst of exhausted new parents: While most newborns lose weight in the first days of life, do you or don’t you offer a little formula after breastfeeding if the weight loss is more than usual?
Red and White Meats Are Equally Bad for Cholesterol
Consuming high levels of red meat or white poultry resulted in higher blood cholesterol levels than consuming a comparable amount of plant proteins.
UCSF Commencement 2019
A roundup of 2019 commencement coverage throughout UCSF.
Algorithm that Tailors Digital Meditation Program Improves Attention and Memory
The intervention, an app called MediTrain, uses a closed-loop algorithm that tailors the length of meditation sessions to the abilities of the participants.